BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Shawcross DL, Shabbir SS, Taylor NJ, Hughes RD. Ammonia and the neutrophil in the pathogenesis of hepatic encephalopathy in cirrhosis. Hepatology. 2010;51:1062-1069. [PMID: 19890967 DOI: 10.1002/hep.23367] [Cited by in Crossref: 118] [Cited by in F6Publishing: 113] [Article Influence: 9.8] [Reference Citation Analysis]
Number Citing Articles
1 Jia JD. Lactulose in the treatment of hepatic encephalopathy: new evidence for an old modality. J Gastroenterol Hepatol 2012;27:1262-3. [PMID: 22823914 DOI: 10.1111/j.1440-1746.2012.07177.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
2 Davies T, Wythe S, O'Beirne J, Martin D, Gilbert-Kawai E. Review article: the role of the microcirculation in liver cirrhosis. Aliment Pharmacol Ther 2017;46:825-35. [PMID: 29023881 DOI: 10.1111/apt.14279] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
3 Sánchez E, Nieto JC, Boullosa A, Vidal S, Sancho FJ, Rossi G, Sancho-Bru P, Oms R, Mirelis B, Juárez C. VSL#3 probiotic treatment decreases bacterial translocation in rats with carbon tetrachloride-induced cirrhosis. Liver Int. 2015;35:735-745. [PMID: 24750552 DOI: 10.1111/liv.12566] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 3.8] [Reference Citation Analysis]
4 Carbonero-aguilar P, Diaz-herrero MDM, Cremades O, Romero-gómez M, Bautista J. Brain biomolecules oxidation in portacaval-shunted rats: Brain biomolecules oxidation. Liver International 2011;31:964-9. [DOI: 10.1111/j.1478-3231.2011.02515.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
5 Macnaughtan J, Jalan R. Clinical and Pathophysiological Consequences of Alterations in the Microbiome in Cirrhosis. American Journal of Gastroenterology 2015;110:1399-410. [DOI: 10.1038/ajg.2015.313] [Cited by in Crossref: 28] [Cited by in F6Publishing: 22] [Article Influence: 4.0] [Reference Citation Analysis]
6 Tran TT, Wei K, Cole S, Mena E, Csete M, King KS. Brain MR Spectroscopy Markers of Encephalopathy Due to Nonalcoholic Steatohepatitis. J Neuroimaging 2020;30:697-703. [PMID: 32705733 DOI: 10.1111/jon.12728] [Reference Citation Analysis]
7 Sepehrinezhad A, Zarifkar A, Namvar G, Shahbazi A, Williams R. Astrocyte swelling in hepatic encephalopathy: molecular perspective of cytotoxic edema. Metab Brain Dis 2020;35:559-78. [PMID: 32146658 DOI: 10.1007/s11011-020-00549-8] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
8 Wu W, Zhang J, Yang W, Hu B, Fallon MB. Role of splenic reservoir monocytes in pulmonary vascular monocyte accumulation in experimental hepatopulmonary syndrome. J Gastroenterol Hepatol 2016;31:1888-94. [PMID: 27029414 DOI: 10.1111/jgh.13388] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
9 Chen Q, Zhang Y, Yue ZD, Zhao HW, Wang L, Fan ZH, Liu FQ. High-mobility group protein B1: A predictive biomarker for hepatic encephalopathy after transjugular intrahepatic portosystemic shunt. J Hepatobiliary Pancreat Sci 2020;27:522-30. [PMID: 32463549 DOI: 10.1002/jhbp.770] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
10 Khan A, Ayub M, Khan WM. Hyperammonemia Is Associated with Increasing Severity of Both Liver Cirrhosis and Hepatic Encephalopathy. Int J Hepatol 2016;2016:6741754. [PMID: 27847646 DOI: 10.1155/2016/6741754] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
11 Patwardhan VR, Jiang ZG, Risech-Neiman Y, Piatkowski G, Afdhal NH, Mukamal K, Curry MP, Tapper EB. Serum Ammonia is Associated With Transplant-free Survival in Hospitalized Patients With Acutely Decompensated Cirrhosis [corrected]. J Clin Gastroenterol. 2016;50:345-350. [PMID: 26565968 DOI: 10.1097/mcg.0000000000000443] [Cited by in Crossref: 16] [Cited by in F6Publishing: 5] [Article Influence: 2.7] [Reference Citation Analysis]
12 Zhou YJ, Yu ZJ. Nutritional assessment and treatment in patients with liver cirrhosis. Shijie Huaren Xiaohua Zazhi 2014; 22(31): 4750-4756 [DOI: 10.11569/wcjd.v22.i31.4750] [Reference Citation Analysis]
13 Jamshidzadeh A, Heidari R, Latifpour Z, Ommati MM, Abdoli N, Mousavi S, Azarpira N, Zarei A, Zarei M, Asadi B, Abasvali M, Yeganeh Y, Jafari F, Saeedi A, Najibi A, Mardani E. Carnosine ameliorates liver fibrosis and hyperammonemia in cirrhotic rats. Clin Res Hepatol Gastroenterol 2017;41:424-34. [PMID: 28283328 DOI: 10.1016/j.clinre.2016.12.010] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 4.4] [Reference Citation Analysis]
14 Wang Q, Wang Y, Yu Z, Li D, Jia B, Li J, Guan K, Zhou Y, Chen Y, Kan Q. Ammonia-induced energy disorders interfere with bilirubin metabolism in hepatocytes. Arch Biochem Biophys. 2014;555-556:16-22. [PMID: 24878366 DOI: 10.1016/j.abb.2014.05.019] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 1.9] [Reference Citation Analysis]
15 Wise HZ, Hung CY, Whiston E, Taylor JW, Cole GT. Extracellular ammonia at sites of pulmonary infection with Coccidioides posadasii contributes to severity of the respiratory disease. Microb Pathog 2013;59-60:19-28. [PMID: 23583291 DOI: 10.1016/j.micpath.2013.04.003] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 3.1] [Reference Citation Analysis]
16 Görg B, Schliess F, Häussinger D. Osmotic and oxidative/nitrosative stress in ammonia toxicity and hepatic encephalopathy. Arch Biochem Biophys. 2013;536:158-163. [PMID: 23567841 DOI: 10.1016/j.abb.2013.03.010] [Cited by in Crossref: 58] [Cited by in F6Publishing: 52] [Article Influence: 6.4] [Reference Citation Analysis]
17 Tuchendler E, Tuchendler PK, Madej G. Immunodeficiency caused by cirrhosis. Clin Exp Hepatol 2018;4:158-64. [PMID: 30324140 DOI: 10.5114/ceh.2018.78119] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
18 Atluri DK, Prakash R, Mullen KD. Pathogenesis, diagnosis, and treatment of hepatic encephalopathy. J Clin Exp Hepatol. 2011;1:77-86. [PMID: 25755319 DOI: 10.1016/s0973-6883(11)60126-6] [Cited by in Crossref: 40] [Cited by in F6Publishing: 18] [Article Influence: 3.6] [Reference Citation Analysis]
19 Akeju O, Kim SE, Vazquez R, Rhee J, Pavone KJ, Hobbs LE, Purdon PL, Brown EN. Spatiotemporal Dynamics of Dexmedetomidine-Induced Electroencephalogram Oscillations. PLoS One 2016;11:e0163431. [PMID: 27711165 DOI: 10.1371/journal.pone.0163431] [Cited by in Crossref: 43] [Cited by in F6Publishing: 39] [Article Influence: 7.2] [Reference Citation Analysis]
20 Breheny CR, Mellanby RJ, Hamilton JA, Gow AG. The effect of ammonia on canine polymorphonuclear cells. Vet Res Commun 2018;42:221-5. [PMID: 29938354 DOI: 10.1007/s11259-018-9725-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
21 Sturgeon JP, Shawcross DL. Recent insights into the pathogenesis of hepatic encephalopathy and treatments. Expert Rev Gastroenterol Hepatol. 2014;8:83-100. [PMID: 24236755 DOI: 10.1586/17474124.2014.858598] [Cited by in Crossref: 32] [Cited by in F6Publishing: 24] [Article Influence: 4.0] [Reference Citation Analysis]
22 Shelton KT, Qu J, Bilotta F, Brown EN, Cudemus G, D'Alessandro DA, Deng H, DiBiasio A, Gitlin JA, Hahm EY, Hobbs LE, Houle TT, Ibala R, Loggia ML, Pavone KJ, Shaefi S, Tolis G, Westover MB, Akeju O. Minimizing ICU Neurological Dysfunction with Dexmedetomidine-induced Sleep (MINDDS): protocol for a randomised, double-blind, parallel-arm, placebo-controlled trial. BMJ Open 2018;8:e020316. [PMID: 29678977 DOI: 10.1136/bmjopen-2017-020316] [Cited by in F6Publishing: 13] [Reference Citation Analysis]
23 Moctezuma-Velázquez C, García-Juárez I, Soto-Solís R, Hernández-Cortés J, Torre A. Nutritional assessment and treatment of patients with liver cirrhosis. Nutrition. 2013;29:1279-1285. [PMID: 23867207 DOI: 10.1016/j.nut.2013.03.017] [Cited by in Crossref: 41] [Cited by in F6Publishing: 38] [Article Influence: 4.6] [Reference Citation Analysis]
24 Belarmino G, Torrinhas RS, Magalhães NV, Heymsfield SB, Waitzberg DL. New anthropometric and biochemical models for estimating appendicular skeletal muscle mass in male patients with cirrhosis. Nutrition 2021;84:111083. [PMID: 33418229 DOI: 10.1016/j.nut.2020.111083] [Reference Citation Analysis]
25 Hai Y, Hong Y, Wang Q, Liu X, Li D. Lactulose mediates suppression of dextran sulfate sodium-induced colon inflammation. Journal of Medical Colleges of PLA 2013;28:65-79. [DOI: 10.1016/s1000-1948(13)60019-2] [Cited by in Crossref: 3] [Article Influence: 0.3] [Reference Citation Analysis]
26 Chen X, Zhai X, Shi J, Liu WW, Tao H, Sun X, Kang Z. Lactulose mediates suppression of dextran sodium sulfate-induced colon inflammation by increasing hydrogen production. Dig Dis Sci. 2013;58:1560-1568. [PMID: 23371012 DOI: 10.1007/s10620-013-2563-7] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 2.0] [Reference Citation Analysis]
27 Li Y, Wu Q, Wang Y, Weng C, He Y, Gao M, Yang G, Li L, Chen F, Shi Y, Amiot BP, Nyberg SL, Bao J, Bu H. Novel spheroid reservoir bioartificial liver improves survival of nonhuman primates in a toxin-induced model of acute liver failure. Theranostics. 2018;8:5562-5574. [PMID: 30555564 DOI: 10.7150/thno.26540] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
28 Kappus MR, Bajaj JS. Covert hepatic encephalopathy: Not as minimal as you might think. Clin Gastroenterol Hepatol. 2012;10:1208-1219. [PMID: 22728384 DOI: 10.1016/j.cgh.2012.05.026] [Cited by in Crossref: 55] [Cited by in F6Publishing: 41] [Article Influence: 5.5] [Reference Citation Analysis]
29 Sutherland GT, Sheedy D, Sheahan PJ, Kaplan W, Kril JJ. Comorbidities, confounders, and the white matter transcriptome in chronic alcoholism. Alcohol Clin Exp Res 2014;38:994-1001. [PMID: 24460866 DOI: 10.1111/acer.12341] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
30 Ma YJ, Cao ZX, Li Y, Feng SY. Proton pump inhibitor use increases hepatic encephalopathy risk: A systematic review and meta-analysis. World J Gastroenterol 2019; 25(21): 2675-2682 [PMID: 31210718 DOI: 10.3748/wjg.v25.i21.2675] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
31 Luo C, Shen G, Liu N, Gong F, Wei X, Yao S, Liu D, Teng X, Ye N, Zhang N, Zhou X, Li J, Yang L, Zhao X, Yang L, Xiang R, Wei Y. Ammonia Drives Dendritic Cells into Dysfunction. J I 2014;193:1080-9. [DOI: 10.4049/jimmunol.1303218] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.8] [Reference Citation Analysis]
32 Campion D, Giovo I, Ponzo P, Saracco GM, Balzola F, Alessandria C. Dietary approach and gut microbiota modulation for chronic hepatic encephalopathy in cirrhosis. World J Hepatol 2019; 11(6): 489-512 [PMID: 31293718 DOI: 10.4254/wjh.v11.i6.489] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 5.3] [Reference Citation Analysis]
33 Stinton L, Swain MG. Fatigue in Cirrhosis: Is Transplant the Answer? Clinical Gastroenterology and Hepatology 2012;10:103-5. [DOI: 10.1016/j.cgh.2011.10.036] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
34 Woodhouse CA, Patel VC, Singanayagam A, Shawcross DL. Review article: the gut microbiome as a therapeutic target in the pathogenesis and treatment of chronic liver disease. Aliment Pharmacol Ther. 2018;47:192-202. [PMID: 29083037 DOI: 10.1111/apt.14397] [Cited by in Crossref: 78] [Cited by in F6Publishing: 70] [Article Influence: 15.6] [Reference Citation Analysis]
35 Grüngreiff K, Reinhold D, Wedemeyer H. The role of zinc in liver cirrhosis. Annals of Hepatology 2016;15:7-16. [DOI: 10.5604/16652681.1184191] [Cited by in Crossref: 64] [Cited by in F6Publishing: 49] [Article Influence: 10.7] [Reference Citation Analysis]
36 McPhail MJ, Bajaj JS, Thomas HC, Taylor-Robinson SD. Pathogenesis and diagnosis of hepatic encephalopathy. Expert Rev Gastroenterol Hepatol. 2010;4:365-378. [PMID: 20528123 DOI: 10.1586/egh.10.32] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 2.5] [Reference Citation Analysis]
37 Bian J, Wang A, Lin J, Wu L, Huang H, Wang S, Yang X, Lu X, Xu Y, Zhao H. Association between proton pump inhibitors and hepatic encephalopathy: A meta-analysis. Medicine (Baltimore) 2017;96:e6723. [PMID: 28445288 DOI: 10.1097/MD.0000000000006723] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 2.6] [Reference Citation Analysis]
38 Sasaki K, Furusawa H, Nagamine K, Tokito S. Charge-accumulative Potentiometric Measurements for Ammonia Detection Using an Enzymatic Cascade Reaction on a Prussian Blue Electrode. Chem Lett 2018;47:1412-5. [DOI: 10.1246/cl.180692] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
39 Heidari R, Mohammadi H, Ghanbarinejad V, Ahmadi A, Ommati MM, Niknahad H, Jamshidzadeh A, Azarpira N, Abdoli N. Proline supplementation mitigates the early stage of liver injury in bile duct ligated rats. J Basic Clin Physiol Pharmacol 2018;30:91-101. [PMID: 30205645 DOI: 10.1515/jbcpp-2017-0221] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 5.3] [Reference Citation Analysis]
40 Ommati MM, Jamshidzadeh A, Niknahad H, Mohammadi H, Sabouri S, Heidari R, Abdoli N. N-acetylcysteine treatment blunts liver failure-associated impairment of locomotor activity. PharmaNutrition 2017;5:141-7. [DOI: 10.1016/j.phanu.2017.10.003] [Cited by in Crossref: 21] [Cited by in F6Publishing: 14] [Article Influence: 4.2] [Reference Citation Analysis]
41 Fadayomi AB, Ibala R, Bilotta F, Westover MB, Akeju O. A Systematic Review and Meta-Analysis Examining the Impact of Sleep Disturbance on Postoperative Delirium. Crit Care Med 2018;46:e1204-12. [PMID: 30222634 DOI: 10.1097/CCM.0000000000003400] [Cited by in Crossref: 35] [Cited by in F6Publishing: 12] [Article Influence: 11.7] [Reference Citation Analysis]
42 Zhang Z, Zhai H, Geng J, Yu R, Ren H, Fan H, Shi P. Large-scale survey of gut microbiota associated with MHE via 16S rRNA-based pyrosequencing. Am J Gastroenterol. 2013;108:1601-1611. [PMID: 23877352 DOI: 10.1038/ajg.2013.221] [Cited by in Crossref: 88] [Cited by in F6Publishing: 84] [Article Influence: 9.8] [Reference Citation Analysis]
43 Belarmino G, Gonzalez MC, Torrinhas RS, Sala P, Andraus W, D’Albuquerque LAC, Pereira RMR, Caparbo VF, Ravacci GR, Damiani L, Heymsfield SB, Waitzberg DL. Phase angle obtained by bioelectrical impedance analysis independently predicts mortality in patients with cirrhosis. World J Hepatol 2017; 9(7): 401-408 [PMID: 28321276 DOI: 10.4254/wjh.v9.i7.401] [Cited by in Crossref: 37] [Cited by in F6Publishing: 36] [Article Influence: 7.4] [Reference Citation Analysis]
44 Crawford AH, Cardy TJA. Is there a link between bacteriuria and a reversible encephalopathy in dogs and cats? J Small Anim Pract 2020;61:467-74. [PMID: 32743843 DOI: 10.1111/jsap.13178] [Reference Citation Analysis]
45 Patil A, Khillan V, Thakur M, Kale P, Bihari C. Antimicrobial-Induced Cytopenia and Bone Marrow Hypocellularity in Patients with Cirrhosis. Bone Marrow Res 2018;2018:4029648. [PMID: 29888008 DOI: 10.1155/2018/4029648] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
46 Wang WW, Zhang Y, Huang XB, You N, Zheng L, Li J. Fecal microbiota transplantation prevents hepatic encephalopathy in rats with carbon tetrachloride-induced acute hepatic dysfunction. World J Gastroenterol 2017; 23(38): 6983-6994 [PMID: 29097871 DOI: 10.3748/wjg.v23.i38.6983] [Cited by in CrossRef: 38] [Cited by in F6Publishing: 34] [Article Influence: 7.6] [Reference Citation Analysis]
47 Taylor NJ, Ma Y, Shawcross DL. Editorial: neutrophil dysfunction in patients with cirrhosis--authors' reply. Aliment Pharmacol Ther 2014;40:987. [PMID: 25229816 DOI: 10.1111/apt.12935] [Reference Citation Analysis]
48 Hadjihambi A, Harrison IF, Costas-Rodríguez M, Vanhaecke F, Arias N, Gallego-Durán R, Mastitskaya S, Hosford PS, Olde Damink SWM, Davies N, Habtesion A, Lythgoe MF, Gourine AV, Jalan R. Impaired brain glymphatic flow in experimental hepatic encephalopathy. J Hepatol 2019;70:40-9. [PMID: 30201461 DOI: 10.1016/j.jhep.2018.08.021] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 6.3] [Reference Citation Analysis]
49 Ye S, Feng S, Huang L, Bian S. Recent Progress in Wearable Biosensors: From Healthcare Monitoring to Sports Analytics. Biosensors (Basel) 2020;10:E205. [PMID: 33333888 DOI: 10.3390/bios10120205] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
50 Pierzchala K, Simicic D, Sienkiewicz A, Sessa D, Mitrea S, Braissant O, McLin VA, Gruetter R, Cudalbu C. Central nervous system and systemic oxidative stress interplay with inflammation in a bile duct ligation rat model of type C hepatic encephalopathy. Free Radic Biol Med 2022;178:295-307. [PMID: 34890769 DOI: 10.1016/j.freeradbiomed.2021.12.011] [Reference Citation Analysis]
51 Li X, Partovi S, Coronado WM, Gadani S, Martin C, Thompson D, Levitin A, Kapoor B. Hepatic Encephalopathy After TIPS Placement: Predictive Factors, Prevention Strategies, and Management. Cardiovasc Intervent Radiol 2022. [PMID: 34981195 DOI: 10.1007/s00270-021-03045-3] [Reference Citation Analysis]
52 Cheon SY, Song J. The Association between Hepatic Encephalopathy and Diabetic Encephalopathy: The Brain-Liver Axis. Int J Mol Sci 2021;22:E463. [PMID: 33466498 DOI: 10.3390/ijms22010463] [Reference Citation Analysis]
53 Tranah TH, Vijay GK, Ryan JM, Shawcross DL. Systemic inflammation and ammonia in hepatic encephalopathy. Metab Brain Dis. 2013;28:1-5. [PMID: 23224356 DOI: 10.1007/s11011-012-9370-2] [Cited by in Crossref: 67] [Cited by in F6Publishing: 62] [Article Influence: 6.7] [Reference Citation Analysis]
54 Kim YK, Song J. Therapeutic Applications of Resveratrol in Hepatic Encephalopathy through Its Regulation of the Microbiota, Brain Edema, and Inflammation. J Clin Med 2021;10:3819. [PMID: 34501267 DOI: 10.3390/jcm10173819] [Reference Citation Analysis]
55 Manakkat Vijay GK, Taylor NJ, Shawcross DL. The quest for the elusive factors that underpin neutrophil dysfunction in cirrhosis goes on. J Hepatol 2012;56:1212-3. [PMID: 22127281 DOI: 10.1016/j.jhep.2011.10.013] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
56 Riggio O, Ridola L, Pasquale C. Hepatic encephalopathy therapy: An overview. World J Gastrointest Pharmacol Ther 2010; 1(2): 54-63 [PMID: 21577297 DOI: 10.4292/wjgpt.v1.i2.54] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
57 Wendon J, Bernal W, Willars C, Auzinger G. Critical care and cirrhosis: outcome and benefit. Curr Opin Crit Care. 2011;17:533-537. [PMID: 21844797 DOI: 10.1097/MCC.0b013e32834ab06f] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
58 Vairappan B, Sundhar M, Srinivas BH. Resveratrol Restores Neuronal Tight Junction Proteins Through Correction of Ammonia and Inflammation in CCl4-Induced Cirrhotic Mice. Mol Neurobiol. 2019;56:4718-4729. [PMID: 30377987 DOI: 10.1007/s12035-018-1389-x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 3.5] [Reference Citation Analysis]
59 Heidari R, Jamshidzadeh A, Ghanbarinejad V, Ommati MM, Niknahad H. Taurine supplementation abates cirrhosis-associated locomotor dysfunction. Clin Exp Hepatol 2018;4:72-82. [PMID: 29904723 DOI: 10.5114/ceh.2018.75956] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 3.5] [Reference Citation Analysis]
60 Aldridge DR, Tranah EJ, Shawcross DL. Pathogenesis of hepatic encephalopathy: role of ammonia and systemic inflammation. J Clin Exp Hepatol. 2015;5:S7-S20. [PMID: 26041962 DOI: 10.1016/j.jceh.2014.06.004] [Cited by in Crossref: 108] [Cited by in F6Publishing: 90] [Article Influence: 13.5] [Reference Citation Analysis]
61 Tapper EB, Jiang ZG, Patwardhan VR. Refining the ammonia hypothesis: a physiology-driven approach to the treatment of hepatic encephalopathy. Mayo Clin Proc. 2015;90:646-658. [PMID: 25865476 DOI: 10.1016/j.mayocp.2015.03.003] [Cited by in Crossref: 80] [Cited by in F6Publishing: 60] [Article Influence: 11.4] [Reference Citation Analysis]
62 Mathew LM, Woode RA, Axiak-bechtel SM, Amorim JR, Declue AE. Resveratrol administration increases phagocytosis, decreases oxidative burst, and promotes pro-inflammatory cytokine production in healthy dogs. Veterinary Immunology and Immunopathology 2018;203:21-9. [DOI: 10.1016/j.vetimm.2018.07.013] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
63 Sipeki N, Antal-Szalmas P, Lakatos PL, Papp M. Immune dysfunction in cirrhosis. World J Gastroenterol 2014; 20(10): 2564-2577 [PMID: 24627592 DOI: 10.3748/wjg.v20.i10.2564] [Cited by in CrossRef: 97] [Cited by in F6Publishing: 78] [Article Influence: 12.1] [Reference Citation Analysis]
64 Shawcross D, Sharifi Y, Canavan J, Yeoman A, Abeles R, Taylor N, Auzinger G, Bernal W, Wendon J. Infection and systemic inflammation, not ammonia, are associated with Grade 3/4 hepatic encephalopathy, but not mortality in cirrhosis. Journal of Hepatology 2011;54:640-9. [DOI: 10.1016/j.jhep.2010.07.045] [Cited by in Crossref: 154] [Cited by in F6Publishing: 136] [Article Influence: 14.0] [Reference Citation Analysis]
65 Farshad O, Keshavarz P, Heidari R, Farahmandnejad M, Azhdari S, Jamshidzadeh A. The Potential Neuroprotective Role of Citicoline in Hepatic Encephalopathy. J Exp Pharmacol 2020;12:517-27. [PMID: 33235522 DOI: 10.2147/JEP.S261986] [Reference Citation Analysis]
66 Martínez J, Hernández-Gea V, Albillos A. Reply to: "Potential novel approaches to prevent the risk of infection in patients with variceal bleeding". J Hepatol 2021:S0168-8278(21)02237-6. [PMID: 34883155 DOI: 10.1016/j.jhep.2021.11.028] [Reference Citation Analysis]
67 Nie F, Wang N, Zheng J, Zhang J. An ultrasensitive post chemiluminescence reaction of ammonium in NBS–dichlorofluorescein system and its application. Talanta 2011;84:1063-7. [DOI: 10.1016/j.talanta.2011.03.005] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
68 Cerejeira J, Firmino H, Vaz-serra A, Mukaetova-ladinska EB. The neuroinflammatory hypothesis of delirium. Acta Neuropathol 2010;119:737-54. [DOI: 10.1007/s00401-010-0674-1] [Cited by in Crossref: 205] [Cited by in F6Publishing: 174] [Article Influence: 17.1] [Reference Citation Analysis]
69 Seyan AS, Hughes RD, Shawcross DL. Changing face of hepatic encephalopathy: Role of inflammation and oxidative stress. World J Gastroenterol 2010; 16(27): 3347-3357 [PMID: 20632436 DOI: 10.3748/wjg.v16.i27.3347] [Cited by in CrossRef: 71] [Cited by in F6Publishing: 62] [Article Influence: 5.9] [Reference Citation Analysis]
70 Carvalho L, Kelley D, Labato MA, Webster CR. Hyperammonemia in azotemic cats. J Feline Med Surg 2021;23:700-7. [PMID: 33215950 DOI: 10.1177/1098612X20972039] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
71 Macnaughtan J, Jalan R. Clinical and pathophysiological consequences of alterations in the microbiome in cirrhosis. Am J Gastroenterol. 2015;110:1399-1410; quiz 1411. [PMID: 26416191 DOI: 10.1038/ajg.2015] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
72 Siddique A, Kowdley K. Gut instinct: rifaximin for the prevention of hepatic encephalopathy. Hepatology 2010;52:792-4. [PMID: 20683970 DOI: 10.1002/hep.23822] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
73 Skowrońska M, Albrecht J. Oxidative and nitrosative stress in ammonia neurotoxicity. Neurochem Int 2013;62:731-7. [PMID: 23142151 DOI: 10.1016/j.neuint.2012.10.013] [Cited by in F6Publishing: 51] [Reference Citation Analysis]
74 Wilkinson DJ, Smeeton NJ, Castle PC, Watt PW. Absence of neuropsychological impairment in hyperammonaemia in healthy young adults; possible synergism in development of hepatic encephalopathy (HE) symptoms? Metab Brain Dis. 2011;26:203-212. [PMID: 21773808 DOI: 10.1007/s11011-011-9251-0] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
75 Merino J, Aller MA, Rubio S, Arias N, Nava MP, Loscertales M, Arias J, Arias JL. Gut-brain chemokine changes in portal hypertensive rats. Dig Dis Sci. 2011;56:2309-2317. [PMID: 21347560 DOI: 10.1007/s10620-011-1625-y] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
76 Bona L, van Staaveren N, Pokharel BB, van Krimpen M, Harlander-Matauschek A. The Effect of Low Protein Energy-Rich Diets on Plasma Hepatic Markers, Hepatic Damage, and Discrimination Reversal Learning in Young Female Chicks. Front Vet Sci 2018;5:107. [PMID: 30177972 DOI: 10.3389/fvets.2018.00107] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
77 Luo M, Guo JY, Cao WK. Inflammation: A novel target of current therapies for hepatic encephalopathy in liver cirrhosis. World J Gastroenterol 2015; 21(41): 11815-11824 [PMID: 26557005 DOI: 10.3748/wjg.v21.i41.11815] [Cited by in CrossRef: 28] [Cited by in F6Publishing: 21] [Article Influence: 4.0] [Reference Citation Analysis]
78 Pozdeev VI, Lang E, Görg B, Bidmon HJ, Shinde PV, Kircheis G, Herebian D, Pfeffer K, Lang F, Häussinger D, Lang KS, Lang PA. TNFα induced up-regulation of Na+,K+,2Cl- cotransporter NKCC1 in hepatic ammonia clearance and cerebral ammonia toxicity. Sci Rep 2017;7:7938. [PMID: 28801579 DOI: 10.1038/s41598-017-07640-8] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.6] [Reference Citation Analysis]
79 Nieto JC, Sánchez E, Román E, Vidal S, Oliva L, Guarner-Argente C, Poca M, Torras X, Juárez C, Guarner C, Soriano G. Cytokine production in patients with cirrhosis and TLR4 polymorphisms. World J Gastroenterol 2014; 20(46): 17516-17524 [PMID: 25516666 DOI: 10.3748/wjg.v20.i46.17516] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
80 Sharma P, Agrawal A, Sharma BC, Sarin SK. Prophylaxis of hepatic encephalopathy in acute variceal bleed: a randomized controlled trial of lactulose versus no lactulose. J Gastroenterol Hepatol. 2011;26:996-1003. [PMID: 21129028 DOI: 10.1111/j.1440-1746.2010.06596.x] [Cited by in Crossref: 56] [Cited by in F6Publishing: 35] [Article Influence: 5.1] [Reference Citation Analysis]
81 Weiss N, Barbier Saint Hilaire P, Colsch B, Isnard F, Attala S, Schaefer A, Amador MDM, Rudler M, Lamari F, Sedel F, Thabut D, Junot C. Cerebrospinal fluid metabolomics highlights dysregulation of energy metabolism in overt hepatic encephalopathy. Journal of Hepatology 2016;65:1120-30. [DOI: 10.1016/j.jhep.2016.07.046] [Cited by in Crossref: 62] [Cited by in F6Publishing: 49] [Article Influence: 10.3] [Reference Citation Analysis]
82 Minemura M, Tajiri K, Shimizu Y. Liver involvement in systemic infection. World J Hepatol 2014; 6(9): 632-642 [PMID: 25276279 DOI: 10.4254/wjh.v6.i9.632] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 3.1] [Reference Citation Analysis]
83 Iadevaia MD, Prete AD, Cesaro C, Gaeta L, Zulli C, Loguercio C. Rifaximin in the treatment of hepatic encephalopathy. Hepat Med. 2011;3:109-117. [PMID: 24367227 DOI: 10.2147/hmer.s11988] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
84 Wang QM, Ji Q, Duan ZJ, Zhang M, Chang QY. A study on the position and etiology of infection in cirrhotic patients: A potential precipitating factor contributing to hepatic encephalopathy. Exp Ther Med 2013;6:584-90. [PMID: 24137231 DOI: 10.3892/etm.2013.1137] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
85 Mallet M, Weiss N, Thabut D, Rudler M. Why and when to measure ammonemia in cirrhosis? Clin Res Hepatol Gastroenterol 2018;42:505-11. [PMID: 29551609 DOI: 10.1016/j.clinre.2018.01.004] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
86 Butterworth RF. Neuroinflammation in acute liver failure: mechanisms and novel therapeutic targets. Neurochem Int 2011;59:830-6. [PMID: 21864609 DOI: 10.1016/j.neuint.2011.07.014] [Cited by in Crossref: 49] [Cited by in F6Publishing: 44] [Article Influence: 4.5] [Reference Citation Analysis]
87 Dennis CV, Sheahan PJ, Graeber MB, Sheedy DL, Kril JJ, Sutherland GT. Microglial proliferation in the brain of chronic alcoholics with hepatic encephalopathy. Metab Brain Dis 2014;29:1027-39. [PMID: 24346482 DOI: 10.1007/s11011-013-9469-0] [Cited by in Crossref: 36] [Cited by in F6Publishing: 34] [Article Influence: 4.0] [Reference Citation Analysis]
88 Butterworth RF. Reprint of: Neuroinflammation in acute liver failure: mechanisms and novel therapeutic targets. Neurochem Int 2012;60:715-22. [PMID: 22504574 DOI: 10.1016/j.neuint.2012.03.014] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
89 Ianiro G, Tilg H, Gasbarrini A. Antibiotics as deep modulators of gut microbiota: between good and evil. Gut. 2016;65:1906-1915. [PMID: 27531828 DOI: 10.1136/gutjnl-2016-312297] [Cited by in Crossref: 217] [Cited by in F6Publishing: 196] [Article Influence: 36.2] [Reference Citation Analysis]
90 Bajaj JS, Lauridsen M, Tapper EB, Duarte-rojo A, Rahimi RS, Tandon P, Shawcross DL, Thabut D, Dhiman RK, Romero-gomez M, Sharma BC, Montagnese S. Important Unresolved Questions in the Management of Hepatic Encephalopathy: An ISHEN Consensus. Am J Gastroenterol 2020;115:989-1002. [DOI: 10.14309/ajg.0000000000000603] [Cited by in Crossref: 18] [Cited by in F6Publishing: 7] [Article Influence: 9.0] [Reference Citation Analysis]
91 Saleh DO, Mansour DF, Fayez AM. Thioacetamide-induced acute hepatic encephalopathy: central vs peripheral effect of Allicin. Metab Brain Dis 2021;36:1331-40. [PMID: 33765229 DOI: 10.1007/s11011-021-00695-7] [Reference Citation Analysis]
92 Gundling F, Zelihic E, Seidl H, Haller B, Umgelter A, Schepp W, Dodt C. How to diagnose hepatic encephalopathy in the emergency department. Annals of Hepatology 2013;12:108-14. [DOI: 10.1016/s1665-2681(19)31392-4] [Cited by in Crossref: 25] [Article Influence: 2.8] [Reference Citation Analysis]
93 Findlay JY, Fix OK, Paugam-Burtz C, Liu L, Sood P, Tomlanovich SJ, Emond J. Critical care of the end-stage liver disease patient awaiting liver transplantation. Liver Transpl. 2011;17:496-510. [PMID: 21506240 DOI: 10.1002/lt.22269] [Cited by in Crossref: 37] [Cited by in F6Publishing: 21] [Article Influence: 3.4] [Reference Citation Analysis]
94 Butterworth RF. Hepatic encephalopathy: a central neuroinflammatory disorder? Hepatology. 2011;53:1372-1376. [PMID: 21480337 DOI: 10.1002/hep.24228] [Cited by in Crossref: 136] [Cited by in F6Publishing: 122] [Article Influence: 12.4] [Reference Citation Analysis]
95 Possamai LA, Thursz MR, Wendon JA, Antoniades CG. Modulation of monocyte/macrophage function: A therapeutic strategy in the treatment of acute liver failure. J Hepatol. 2014;61:439-445. [PMID: 24703954 DOI: 10.1016/j.jhep.2014.03.031] [Cited by in Crossref: 70] [Cited by in F6Publishing: 66] [Article Influence: 8.8] [Reference Citation Analysis]
96 Zhong B, Jiang K, Wang L, Shen G. Wearable Sweat Loss Measuring Devices: From the Role of Sweat Loss to Advanced Mechanisms and Designs. Adv Sci (Weinh) 2021;:e2103257. [PMID: 34713981 DOI: 10.1002/advs.202103257] [Reference Citation Analysis]
97 Dhanda S, Sandhir R. Blood-Brain Barrier Permeability Is Exacerbated in Experimental Model of Hepatic Encephalopathy via MMP-9 Activation and Downregulation of Tight Junction Proteins. Mol Neurobiol 2018;55:3642-59. [PMID: 28523565 DOI: 10.1007/s12035-017-0521-7] [Cited by in Crossref: 15] [Cited by in F6Publishing: 21] [Article Influence: 3.0] [Reference Citation Analysis]
98 Chen Y, Sheen J, Tain Y, Chen C, Tiao M, Huang Y, Hsieh C, Huang L. Alterations in NADPH oxidase expression and blood–brain barrier in bile duct ligation-treated young rats: Effects of melatonin. Neurochemistry International 2012;60:751-8. [DOI: 10.1016/j.neuint.2012.03.021] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 2.1] [Reference Citation Analysis]
99 Heidari R. Brain mitochondria as potential therapeutic targets for managing hepatic encephalopathy. Life Sciences 2019;218:65-80. [DOI: 10.1016/j.lfs.2018.12.030] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
100 Mohammadigheisar M, Shouldice VL, Torrey S, Widowski T, Kiarie EG. Research Note: Comparative gastrointestinal, tibia, and plasma attributes in 48-day-old fast- and slow-growing broiler chicken strains. Poult Sci 2020;99:3086-91. [PMID: 32475445 DOI: 10.1016/j.psj.2020.01.032] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
101 Burkard T, Biedermann A, Herold C, Dietlein M, Rauch M, Diefenbach M. Treatment with a potassium-iron-phosphate-citrate complex improves PSE scores and quality of life in patients with minimal hepatic encephalopathy: a multicenter, randomized, placebo-controlled, double-blind clinical trial. Eur J Gastroenterol Hepatol. 2013;25:352-358. [PMID: 23117470 DOI: 10.1097/MEG.0b013e32835afaa5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
102 Magata F, Morino I, Teramura M, Tsunoda E, Kawashima C, Haneda S, Miyamoto A, Kida K, Shimizu T. Impact of metritis on the generation of reactive oxygen species by circulating phagocytes and plasma lipopolysaccharide concentration in peripartum dairy cows. Anim Sci J 2017;88:248-53. [PMID: 27313082 DOI: 10.1111/asj.12642] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
103 Guinovart T, Bandodkar AJ, Windmiller JR, Andrade FJ, Wang J. A potentiometric tattoo sensor for monitoring ammonium in sweat. Analyst 2013;138:7031-8. [PMID: 24098883 DOI: 10.1039/c3an01672b] [Cited by in Crossref: 177] [Cited by in F6Publishing: 132] [Article Influence: 22.1] [Reference Citation Analysis]
104 Hadjihambi A, Arias N, Sheikh M, Jalan R. Hepatic encephalopathy a critical current review. Hepatol Int. 2018;12:135-147. [PMID: 28770516 DOI: 10.1007/s12072-017-9812-3] [Cited by in Crossref: 58] [Cited by in F6Publishing: 51] [Article Influence: 11.6] [Reference Citation Analysis]
105 Montagnese S, Biancardi A, Schiff S, Carraro P, Carlà V, Mannaioni G, Moroni F, Tono N, Angeli P, Gatta A. Different biochemical correlates for different neuropsychiatric abnormalities in patients with cirrhosis. Hepatology. 2011;53:558-566. [PMID: 21274876 DOI: 10.1002/hep.24043] [Cited by in Crossref: 50] [Cited by in F6Publishing: 47] [Article Influence: 4.5] [Reference Citation Analysis]
106 Steinbrenner H, Sies H. Selenium homeostasis and antioxidant selenoproteins in brain: implications for disorders in the central nervous system. Arch Biochem Biophys. 2013;536:152-157. [PMID: 23500141 DOI: 10.1016/j.abb.2013.02.021] [Cited by in Crossref: 104] [Cited by in F6Publishing: 98] [Article Influence: 11.6] [Reference Citation Analysis]
107 Tsunoda E, Gross JJ, Kawashima C, Bruckmaier RM, Kida K, Miyamoto A. Feed-derived volatile basic nitrogen increases reactive oxygen species production of blood leukocytes in lactating dairy cows: Poor Fermented Silage and Cow Metabolism. Anim Sci J 2017;88:125-33. [DOI: 10.1111/asj.12608] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
108 Grüngreiff K, Gottstein T, Reinhold D, Blindauer CA. Albumin Substitution in Decompensated Liver Cirrhosis: Don't Forget Zinc. Nutrients 2021;13:4011. [PMID: 34836265 DOI: 10.3390/nu13114011] [Reference Citation Analysis]
109 Coltart I, Tranah TH, Shawcross DL. Inflammation and hepatic encephalopathy. Arch Biochem Biophys. 2013;536:189-196. [PMID: 23583306 DOI: 10.1016/j.abb.2013.03.016] [Cited by in Crossref: 68] [Cited by in F6Publishing: 59] [Article Influence: 7.6] [Reference Citation Analysis]
110 Cichoż-Lach H, Michalak A. Current pathogenetic aspects of hepatic encephalopathy and noncirrhotic hyperammonemic encephalopathy. World J Gastroenterol 2013; 19(1): 26-34 [PMID: 23326159 DOI: 10.3748/wjg.v19.i1.26] [Cited by in CrossRef: 37] [Cited by in F6Publishing: 30] [Article Influence: 4.1] [Reference Citation Analysis]
111 Lidbury JA, Cook AK, Steiner JM. Hepatic encephalopathy in dogs and cats. J Vet Emerg Crit Care (San Antonio) 2016;26:471-87. [PMID: 27060899 DOI: 10.1111/vec.12473] [Cited by in Crossref: 20] [Cited by in F6Publishing: 14] [Article Influence: 3.3] [Reference Citation Analysis]
112 Moreau R, Périanin A, Arroyo V. Review of Defective NADPH Oxidase Activity and Myeloperoxidase Release in Neutrophils From Patients With Cirrhosis. Front Immunol 2019;10:1044. [PMID: 31134093 DOI: 10.3389/fimmu.2019.01044] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
113 Moratalla A, Ampuero J, Bellot P, Gallego-Durán R, Zapater P, Roger M, Figueruela B, Martínez-Moreno B, González-Navajas JM, Such J, Romero-Gómez M, Francés R. Lactulose reduces bacterial DNA translocation, which worsens neurocognitive shape in cirrhotic patients with minimal hepatic encephalopathy. Liver Int 2017;37:212-23. [PMID: 27388776 DOI: 10.1111/liv.13200] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 2.5] [Reference Citation Analysis]
114 Zhang M, Duan ZJ. Retrospective analysis of factors influencing the development and progression of hepatic encephalopathy in patients with hepatitis B virus-related cirrhosis. Shijie Huaren Xiaohua Zazhi 2012; 20(13): 1148-1155 [DOI: 10.11569/wcjd.v20.i13.1148] [Reference Citation Analysis]
115 Bian T, Zhang X, He G, Duan Z, Dong C, Li X, Guo N. Citric acid-loaded W 1 /O/W 2 multiple emulsions efficiently remove colonic ammonia both in vitro and in vivo. Journal of Dispersion Science and Technology 2017;38:1-7. [DOI: 10.1080/01932691.2015.1038750] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
116 Tapper EB. Predicting Overt Hepatic Encephalopathy for the Population With Cirrhosis. Hepatology 2019;70:403-9. [PMID: 30703852 DOI: 10.1002/hep.30533] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
117 . Liver. Canine and Feline Gastroenterology. Elsevier; 2013. pp. 849-957. [DOI: 10.1016/b978-1-4160-3661-6.00061-4] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
118 Yadav SK, Gupta RK, Saraswat VA, Rangan M, Thomas MA, Rutella S, Danese S, Wang E, Marincola FM, Haris M. Reduced cortical thickness in patients with acute-on-chronic liver failure due to non-alcoholic etiology. J Transl Med 2015;13:322. [PMID: 26444271 DOI: 10.1186/s12967-015-0679-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
119 Breheny CR, Handel I, Banner S, Milne EM, Morrison LR, Smith SH, Kilpatrick S, Gow A, Mellanby RJ. Neutrophilia is associated with a poorer clinical outcome in dogs with chronic hepatitis. Vet Rec 2020;187:234. [PMID: 31974266 DOI: 10.1136/vr.105533] [Cited by in F6Publishing: 1] [Reference Citation Analysis]